Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?

ISSN： 0944-1174

Source： Journal of Gastroenterology, Vol.37, Iss.3, 2002-03, pp. : 235-237

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Angiotensin II Type 1 Receptor Blockade: a Novel Therapeutic Concept

By JOHNSTON COLIN I.

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 9-13

Informa Healthcare

Access to resources Recommend Favorite

The increased angiotensin II (type 1) receptor density in myocardium of type 2 diabetic patients is prevented by blockade of the renin–angiotensin system

By Reuter H. Adam C. Grönke S. Zobel C. Frank K. Müller-Ehmsen J. Brabender J. Schwinger R.

Diabetologia, Vol. 49, Iss. 12, 2006-12 ,pp. : 3067-3074

Springer Publishing Company

Access to resources Recommend Favorite

Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome

By Brillante Divina Gracilla O'Sullivan Anthony John Brillante Ruby Esmeralda Howes Laurence Guy

Blood Pressure, Vol. 18, Iss. 3, 2009-06 ,pp. : 142-148

Informa Healthcare

Access to resources Recommend Favorite

Improving Prognosis in Hypertension: Exploring the Benefits of Angiotensin II Type 1 Receptor Blockade

By RUILOPE LUIS

Blood Pressure, Vol. 9, Iss. 1, 2000-05 ,pp. : 31-35

Informa Healthcare

Access to resources Recommend Favorite

Effects of Selective Angiotensin II Type 1 Receptor Blockade with Losartan on Arterial Compliance in Patients with Mild Essential Hypertension

By KLEMSDAL TOR O. MOAN ANDREAS KJELDSEN SVERRE E.

Blood Pressure, Vol. 8, Iss. 4, 1999-12 ,pp. : 214-219

Informa Healthcare

Access to resources Recommend Favorite